0001193125-23-010945.txt : 20230223 0001193125-23-010945.hdr.sgml : 20230223 20230119160059 ACCESSION NUMBER: 0001193125-23-010945 CONFORMED SUBMISSION TYPE: CORRESP PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20230119 FILER: COMPANY DATA: COMPANY CONFORMED NAME: IMARA Inc. CENTRAL INDEX KEY: 0001672619 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 811523849 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: CORRESP BUSINESS ADDRESS: STREET 1: 1309 BEACON STREET STREET 2: SUITE 300 CITY: BROOKLINE STATE: MA ZIP: 02446 BUSINESS PHONE: 617-206-2020 MAIL ADDRESS: STREET 1: 1309 BEACON STREET STREET 2: SUITE 300 CITY: BROOKLINE STATE: MA ZIP: 02446 CORRESP 1 filename1.htm CORRESP

Imara Inc.

1309 Beacon Street, Suite 300, Office 341

Brookline, MA 02446

January 19, 2023

VIA EDGAR

Securities and Exchange Commission

Division of Corporation Finance

100 F Street, N.E.

Washington, D.C. 20549

Attention:           Jenn Do

Kevin Vaughn

Lauren Hamill

Tim Buchmiller

 

  Re:

Imara Inc.

Registration Statement on Form S-4

File No. 333-268300

Request for Acceleration

Ladies and Gentlemen:

Pursuant to Rule 461 promulgated under the Securities Act of 1933, as amended, Imara Inc. (the “Registrant”) hereby requests acceleration of the effective date of its Registration Statement on Form S-4 (File No. 333-268300), as amended (the “Registration Statement”), so that it may become effective at 4:00 p.m. Eastern time on January 23, 2023, or as soon thereafter as practicable.

 

Very truly yours,
IMARA INC.
By:  

/s/ Rahul D. Ballal, Ph.D.

  Name:   Rahul D. Ballal, Ph.D.
  Title:   President and Chief Executive Officer